Is Dextromethorphan (DXM) safe for babies and kids?
Moderate risk for kidsInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Dextromethorphan (DXM) poses heightened risk.
What is dextromethorphan (dxm)?
The IUPAC name is (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene.
Also known as: (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene, dextromethorphan, d-Methorphan, delta-Methorphan.
- IUPAC name
- (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
- CAS number
- 125-71-3
- Molecular formula
- C18H25NO
- Molecular weight
- 271.4 g/mol
- SMILES
- CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
- PubChem CID
- 5360696
Risk for babies
Moderate riskInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Dextromethorphan (DXM) poses heightened risk.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Elevated riskDextromethorphan (DXM) poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.
Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.
Regulatory consensus
1 regulatory bodyhas classified Dextromethorphan (DXM).
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EPA CTX / Skin-Eye | — | Skin Irritation: SkinIrr2 (score: high) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter dextromethorphan (dxm)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Dextromethorphan (DXM):
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is dextromethorphan (dxm) safe for kids?
Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Dextromethorphan (DXM) poses heightened risk.
What products contain dextromethorphan (dxm)?
Dextromethorphan (DXM) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to dextromethorphan (dxm)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See Dextromethorphan (DXM) in the baby app
Look up products containing dextromethorphan (dxm), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- FDA Drug Safety Communication: DXM Cough Suppressants — Not for children <4 years; CYP2D6 poor metabolizer drug interaction; serotonin syndrome risk; adolescent abuse robotripping; Coricidin HBP triple-C abuse; NMDA antagonism high dose (2010) (2010) — regulatory
- American Association of Poison Control Centers (AAPCC): National Poison Data System Annual Report — Pediatric cocaine/stimulant exposures; body packing emergencies; levamisole agranulocytosis; accidental child ingestion outcomes (2022) (2022) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →